Obermatt
See Similar Stocks →

Cabaletta Bio

NSQ:CABA · US12674W1099
BiotechnologySmall

360° View

no current rank
Price/Sales—
Price/Earnings43
Price/Book91
Dividend Yield—
Revenue Growth—
Profit Growth29
Capital Growth1
TSR 52w43
Leverage26
Liquidity40
Refinancing41
Combined—
Analyst Opinions13
Pro Holdings31
Opinion Changes50
Market Pulse67

Profile

CountryUSA
IndustryBiotechnology
SizeSmall
TypePublic Company
ExchangeNASDAQGS
Founded2017
Employees163
Websitecabalettabio.com
ISINUS12674W1099
Last UpdateApr 2, 2026
Index & Theme
Chronic DiseasesRheumatologyDermatologyImmunologyStem Cell TherapyInflammationNeurologyCentral Nervous SystemBiotechnologyMedicalRoboticsTherapeutics

Description

Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies that have the potential to provide deep and durable, perhaps curative, responses with one-time administration for pat…

Similar Stocks

The companies this stock is ranked against.

Compare Cabaletta Bio with its peers
Kyverna Therapeutics
NSQ:KYTX
6
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Vor Biopharma
NSQ:VOR
—
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Nkarta
NSQ:NKTX
—
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Legend Biotech
NSQ:LEGN
30
CountryUSA
IndustryBiotechnology
SizeMedium
Full Stock Analysis →
Arcellx
NSQ:ACLX
67
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Immunic
NAQ:IMUX
38
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →